PFE250103C33000
- 0.00
- 0.000.00%
Pfizer Newsroom
Pfizer Has Increased Prices on Over 60 Drugs in the U.S. as of Jan. 1
Pfizer Options Spot-On: On January 3rd, 103.45K Contracts Were Traded, With 3.28 Million Open Interest
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Best Income Ideas for 2025: Stocks, Bonds, and Everything in Between
The S&P 500's 10 Worst Performing Stocks in 2023 Fell Again in 2024
AUA Partners With Pfizer to Launch $1.5 Million RFP to Advance Care for Patients With Advanced Prostate Cancer
Santa Claus Came Without Rallying the Troops | Live Stock
Pfizer Rises 5.6% in a Month: How Should You Play the Stock?
Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More
Here's Why Pfizer Inc. (PFE) Is Among The Stocks Targeted By Activist Hedge Funds
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025
The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP
Pfizer (PFE) Advances While Market Declines: Some Information for Investors
Pfizer Options Spot-On: On January 2nd, 147.81K Contracts Were Traded, With 3.26 Million Open Interest
Express News | FDA: Hospira's Heparin Sodium, Injection, 1,000 Units/500 Ml (2 Units/Ml) Available- Website
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer
Pfizer Joins Forces With Atavistik Bio to Unlock Revolutionary Cancer Treatments